SUMMARY OF RELEVANCE
Problem 29 Influenza vaccination during pregnancy prevents serious morbidity in mothers and their 30
infants; however, uptake has been suboptimal historically . 31 What is already known 32 Previous studies have shown that 60% of pregnant women are recommended to receive 33 seasonal influenza vaccine during their pregnancy, and as a result, one in three pregnant 34
women receives an influenza vaccine each year. 35
What this paper adds 36 Uptake improved between 2012 and 2014. Advice from an antenatal care provider was the 37 most important motivator for influenza vaccination in pregnant women, yet 40% of pregnant 38 women were not recommended an influenza vaccine. These results imply there is a greater 39 role for antenatal care providers, including midwives, in encouraging antenatal vaccination 40
and promoting the health of pregnant women and their newborns. 41
INTRODUCTION 42
Antenatal influenza vaccination has been demonstrated to reduce morbidity in both mothers 43 and their infants [1] [2] [3] . Infection with seasonal influenza during pregnancy is associated with 44 severe illness and increased risk of hospitalisation and adverse infant outcomes, including 45 small for gestational age and low birth weight births [4, 5] . Influenza vaccination during 46 pregnancy has been shown to reduce the risk of these poor neonatal health outcomes [6, 7] . 47
Despite the known benefits of maternal influenza vaccination, historically, fewer than 50% of 48 pregnant women in Australia receive an influenza vaccine each year [8] [9] [10] . 49 50 Previous research has found that a recommendation by an antenatal care provider is the 51 primary reason pregnant women get vaccinated against influenza, and lack of discussion with 52 a provider remains a commonly cited reason for non-vaccination [11] [12] [13] . Protecting the infant 53 from infection, perceiving influenza as a serious illness, and believing that the vaccine is safe 54 and effective have also been identified as strong predictors of influenza vaccination during 55 pregnancy [14] [15] [16] . Concerns about the safety of the vaccine for the developing fetus and 56 potential side effects are other commonly cited reasons for non-vaccination among pregnant 57 women [8, 11, 15, 16] . Because information on maternal influenza vaccination has generally 58 been unavailable in Western Australia, the Western Australia Department of Health (WA 59 Health) has conducted an annual survey in Western Australia since 2012. 60
61
It was the goal of this study to use annual survey data to assess trends in uptake of trivalent 62 influenza vaccine (TIV) in pregnant women between 2012 and 2014, as well as factors 63 associated with vaccination and non-vaccination. 64 selected in November each year using the Western Australian Midwives Notification System, 69 which is a legally mandated state-wide data collection of attended births in Western Australia 70 [17] . The sample was randomly selected from all births using a random number generator. 71
Sample size was determined based on the number of participants required to measure vaccine 72 uptake with a precision of ±1.5%. In 2012, mothers residing in non-metropolitan areas were 73 oversampled. In 2013, mothers from two metropolitan health services were oversampled; 74 these oversampling techniques were not repeated in 2014. Selected women were invited to 75 participate in a 10 minute telephone interview; women who declined the invitation were 76 removed from the sample. The remaining women were telephoned by trained interviewers in 77 Women were asked to self-report whether they were immunised against influenza during their 89 most recent pregnancy. Where possible, immunisation providers were contacted to verify the 90 self-reported vaccination status. Women were considered "vaccinated" if they self-reported a 91 vaccination which was verified by their immunisation provider. For women who self-reported 92 immunisations administered by a provider without immunisation records (i.e. private 93 workplace, pharmacy), it was assumed the woman was "vaccinated." Women who self-reported not being vaccinated and those who self-reported being vaccinated but their 95 nominated provider indicated no such vaccination was given were considered "unvaccinated." 96 97 Vaccinated women were asked why they chose to be vaccinated, and unvaccinated women 98 were asked why they were not vaccinated; reasons not listed on the survey were recorded 99 verbatim and coded into themes. 100 101 Demographic information was collected during the survey, including the woman's age, 102 postcode of residence, highest level of education completed, presence of chronic medical 103 conditions, and the primary antenatal care provider for her most recent pregnancy (e.g., 104
private obstetrician, general practitioner, public antenatal hospital clinic, private practice 105 midwife, or other). The postcode of residence provided was used to determine whether the 106 woman lived in a metropolitan or non-metropolitan area as well as the socioeconomic status 107 of the woman, as determined by the Socio-Economic Indexes for Areas (SEIFA) score [19] . 108
Women were assigned into tertiles of socioeconomic status based on these scores. analyses were performed in SAS version 9.4 (SAS Institute Inc., Cary NC, USA).
RESULTS

122
A total of 2,828 women (2012: n=566; 2013: n=1,114; 2014: n=1,148) were telephoned, of 123 whom 2,018 (71.3%) completed the interview (2012: n=416; 2013: n=831; 2014: n=771). Of 124 the 814 women who did not complete an interview, 43.0% could not be contacted after 10 125 attempts, 41.5% had incorrect or disconnected telephone numbers, 7.2% declined 126 participation, 6.8% were non-English speaking, and 1.5% were unavailable at the time of 127 interview. One-half of respondents were between 30 and 45 years of age (53.6%), and two-128 thirds of respondents had post-secondary school qualifications (67.8%); 40.8% were in the 129 highest socioeconomic tertile. The majority of women resided in the metropolitan area (72.9%) 130
and reported no chronic medical conditions (86.8%). 131
132
A total of 783 (38.8%) women self-reported a vaccination during their pregnancy and 756 133 (96.5%) of these women gave permission to verify the vaccination (Figure 1 ). Of these, 718 134 (91.7%) were classified as vaccinated. Records could not be located by the immunisation 135 provider for 65 (8.6%) women and these women were considered unvaccinated. A total of Between 2012 and 2014, the reason women most commonly cited for receiving TIV was to 173 protect the baby (89.7%), followed by receiving a recommendation from a HCP (82.5%). The 174 proportion of women who were immunised during pregnancy in order to protect the baby because a provider recommended the vaccine increased from 78.8% in 2012 to 85.5% in 177 2014, although not significantly (p=0.06) ( Table 2 ). The proportion of unimmunised women 178 who indicated they did not normally get an annual influenza vaccination decreased from 67.0% 179 in 2012 to 39.7% in 2014 (p<0.001). The percentage of women who were not vaccinated 180 because of concerns about potential harm to the baby decreased from 49.6% in 2012 to 42.9% 181 in 2014, although this decrease was only borderline significant (p=0.05). However, the 182 proportion of women who declined vaccination due to potential side effects to the mother did 183 not significantly change between 2012 and 2014 (46.8% to 43.3%, p=0. 22) . [4, 20, 21] , and influenza immunisation during pregnancy has been 196 shown to prevent 36% of respiratory illnesses in mothers and 63% of influenza cases in infants 197 <6 months [2] . Based on the evidence supporting the benefits of seasonal influenza 198 vaccination to mother and infant, the World Health Organisation considers pregnant women 199 the highest priority group for seasonal influenza vaccination programs [22] . Results from our 200 investigation highlight potential strategies for improving maternal influenza vaccine uptake. 201 antenatal clinic, where midwives have extensive access to women in Western Australia, were 205 not recommended TIV. These results suggest that general practitioners, midwives and other 206 antenatal care providers have an important role in protecting their antenatal patients and 207 newborn infants against influenza infection. Considering a provider recommendation for 208 vaccination is the strongest predictor of antenatal vaccination [8] and the majority of women 209 in our study stated they would have been vaccinated had a general practitioner or midwife 210 recommended it to them, general practitioners and midwives could embrace a more active 211 role in the promotion of antenatal immunisation services. Pregnant women view midwives as 212 a trusted source of health information [23] and midwives, both publicly and privately practising, 213 are ideally placed to provide antenatal immunisation information and recommendations during 214 antenatal care visits and parent education sessions. In theory, based on our findings, if 100% 215 of antenatal care providers recommended the vaccine to their pregnant patients, immunisation 216 coverage rates up to 79% would be achievable. 217
218
Other studies suggest that midwives may be less likely to recommend and administer 219 influenza vaccine to pregnant patients as compared with other providers [24] . Our results 220 showed that women who received most of their care at sites where midwives provide care 221 (e.g., public hospital antenatal clinics) were less likely to receive a recommendation for TIV or 222 to receive TIV during pregnancy. Although the majority of midwives agree that vaccinating 223 pregnant women against seasonal influenza is important [25] , researchers have found that 224 midwives may not recommend influenza vaccine to their patients as often as other providers 225 because they do not feel prepared for such conversations [25] . A recent study in the UK 226 suggests that just 26% of midwives feel prepared to provide immunisation advice and only 227 one-third of midwives are willing to immunise pregnant women [25] . Because midwives play 228 an important role in promoting TIV to their patients and successful antenatal and post-natal 229 immunisation programs rely on the support of midwives [26, 27] , it is important to identify 230 barriers in promoting and providing TIV during pregnancy experienced by midwives, education resources are available to healthcare professionals at no cost [28] ; additional 233 immunisation education needs of midwives should be identified in order to provide targeted 234 immunisation education programs for midwives. 235
236
Results from this survey can assist antenatal care providers, including general practitioners, 237 obstetricians, and midwives, to effectively communicate with their pregnant patients for 238 discussing antenatal immunisation. More than 90% of the vaccinated women in our survey 239 reported being immunised to protect their baby. These results are consistent with those from 240 other national and international research efforts [8, 11, 13] indicating this is an important 241 message to convey to pregnant women when discussing immunisation. Unvaccinated women 242 commonly cited concerns about the safety of the vaccine as a reason for remaining 243 unvaccinated. Vaccine safety has been well demonstrated for both mothers and their infants 244
in Australia and internationally [29] [30] [31] . Providers should discuss the demonstrated safety of 245 influenza vaccination during pregnancy when recommending TIV to pregnant patients. The 246 themes identified in this study could be used to develop effective communication materials 247 summarising immunisation information for pregnant women. 248
249
Our study has several limitations which should be considered. First, most of the data were 250 self-reported and, as a result, are subject to reporting bias. Second, 15% of vaccinated women 251 received their vaccination from a provider for whom we could not access the patient's medical 252 record (i.e. immunisations that were provided in a private workplace). It is therefore possible 253 that a portion of these reported vaccination events were errors and these women were in fact 254 unvaccinated; however, given that the proportion of vaccines reportedly administered by 255 providers without access to medical records did not vary over time, it is unlikely that this would 256 explain the trends we observed during the study period. Furthermore, 91% of self-reported 257 vaccinations administered by a provider with immunisation records could be verified, indicating 258 self-report is a valid measure of vaccination status. Finally, some sub-analyses, particularly Additional research should further explore the association between models of antenatal care 261 and recommendations for, and receipt of, TIV during pregnancy. 262 263
Conclusion
264
Influenza vaccination during pregnancy is standard of care in Australia [32] and research in 265 many countries has shown that the recommendation of the antenatal care providers is an 266 important factor in a woman's decision to be vaccinated during pregnancy. Our results showed 267 
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